Ignite Creation Date:
2025-12-24 @ 1:38 PM
Ignite Modification Date:
2026-02-22 @ 3:56 PM
Study NCT ID:
NCT05599295
Status:
COMPLETED
Last Update Posted:
2025-11-25
First Post:
2022-10-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate the Safety of Intravenous Oritavancin for the Treatment of Children With Skin Infections
Sponsor:
Melinta Therapeutics, LLC
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Acute Bacterial Skin and Skin Structure Infection | View |
Keywords: